Evaluation of clinical and laboratory characteristics of patients with bladder cancer in Ardabil province, 2016

Authors

  • Ali Hoseinkhani Department of Surgery, Faculty of Medicine, Ardabil University of Medical Science, Ardabil, Iran
  • Firouz Amani Department of Surgery, Faculty of Medicine, Ardabil University of Medical Science, Ardabil, Iran
  • Yasamin Torabi Department of Surgery, Faculty of Medicine, Ardabil University of Medical Science, Ardabil, Iran

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20180742

Keywords:

Bladder cancer, Laboratory characteristics, Clinical properties, Ardabil

Abstract

Background: Bladder cancer is the most common cancer of the urethra and genital tract and is ranked ninth in terms of its incidence. The aim of this study was to investigate the clinical and laboratory characteristics of patients with bladder cancer in Ardabil province.

Methods: This is a cross-sectional study that has been done on 81 patients with bladder cancer. Necessary information such as age, sex, blood type, RH, family history of bladder cancer, smoking, drug use, tumor stage and grade and type of tumor were collected from the patient's hospital record or by telephone interview.

Results: Sixty seven patients (82.7%) were male. The mean age of patients was 66.9±15.02 years. The blood group A, was the most common type of blood. (39.5%) of all patients, 54.3% had cigarette smoking and 47(58%) live in city. The most common type of tumor grade was high-grade papillary urethral carcinoma (48.1%).The most common stages of the tumor was Ta (40.7%) and the most common clinical manifestation was hematuria (90.1%). 27 patients (33.3%) had a delay of more than 3 months between observation of hematuria and cystoscopy.

Conclusions: The findings showed that the most common grade and stage of the tumor in patients were high-grade papillary urethral carcinoma and Ta; the most prevalent clinical presentation was hematuria; the prevalence of the disease was higher among males, at ages older than 70 years old, in people with a blood type A, and among people living in urban areas; a study with bigger sample size should be done in future in the country Iran.

References

Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289-93.

Fedewa SA, Soliman AS,Ismail K, Hablas A, Seifeldin IA, Ramadan M, et al. Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiol. 2009;33(3–4):176-81.

Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Euro Urol. 2013;63(2):234-41.

Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A. International Variations in Bladder Cancer Incidence and Mortality. Eur Urol. 20147;66(1):59-73.

Koohi F, Salehiniya H. The trend of incidence of bladder cancer in Iran, 2003-2009. UMJ. 2015;26(1):1-9.

Lerner SP, Schoenberg M, Sternberg C, editors. Textbook of bladder cancer. CRC Press; 2006.

Shafi H, Ramaji A, Pasha A, Pasha Y, Kasayan A, Aghajanimir M, et al. A Survey on 175 Cases of Bladder Cancer in the Patients Who Referred to the Hospitals Affiliated to Babol University of Medical Sciences, Iran (2001-2011). JBUMS. 2013;15(2):116-22.

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.

Whelan P. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer. 2008;99 Suppl 1: S90-2.

Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115(1):68-74.

Brookfield KF, Cheung MC, Gomez C, Yang R, Nieder AM, Lee DJ, et al. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer. 2009;115(18):4196-209.

Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, et al. Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies. Int J Cancer. 2000;86(2):289-94.

Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control. 2001;12(5):411-7.

Gaertner RR, Trpeski L, Johnson KC, Canadian Cancer Registries Epidemiology Research Group. A casecontrol study of occupational risk factors for bladder cancer in Canada. Cancer Causes Control 2004; 15(10): 1007-19.

Kogevinas M, Mannetje A, Cordier S, Ranft U, González CA, Vineis P, et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control. 2003;14(10):907-14.

Smailyte G, Kurtinaitis J, Andersen A. Mortality and cancer incidence among Lithuanian cement producing workers. Occup Environ Med. 2004;61(6):529-34.

Cheng L, Lopez-Beltran A, Bostwick DG. Bladder pathology. John Wiley & Sons; 2012.

Sjöström G, Thorstenson A, Jahnson S. Urothelial Carcinoma of the Bladder in Swedish Geriatric Patients:A Population-based Study. MOJ Gerontol Ger. 2017:1(3):1-3.

Sasikumar S, Wijayarathna KS, Karunaratne KA, Gobi U, Pathmeswaran A, Abeygunasekera AM. Pathological characteristics of primary bladder carcinoma treated at a Tertiary Care Hospital and changing demographics of bladder cancer in Sri Lanka. Advances Urol. 2016:1(1):1-6.

Dobbs RW, Hugar LA, Revenig LM, Al-Qassab U, Petros JA, Ritenour CW, Issa MM, Canter DJ. Incidence and clinical characteristics of lower urinary tract symptoms as a presenting symptom for patients with newly diagnosed bladder cancer. International Braz J Urol. 2014;40(2):198-203.

Biswas RR, Mangal S, Guha D, Basu K, Karmakar D. An epidemiological study of cases of urothelial carcinoma of urinary bladder in a tertiary care centre. J Krishna Institute of Med Sci. 2013;2(1):82-8.

Ray D, Mondal R, Acharya S, De S, Mondal S. A retrospective study of bladder cancer and the impact of age, sex and smoking habits related clinicopathological correlations in tribal population of Bankura, WB, India. IOSR J Dent Med Sci. 2013;10 (4):29-32.

Gupta P, Jain M, Kapoor R, Muruganandham K, Srivastava A, Mandhani A. Impact of age and gender on the clinicopathological characteristics of bladder cancer. Indian J Urol: IJU: journal of the Urological Society of India. 2009;25(2):207.

Ramezani M, Naderi N, Almasi A, Sadeghi M. Epidemiological and Clinicopathological Features of Bladder Cancer:A Report from Kermanshah Province, Iran. Iranian J Blood Cancer. 2016;8(2):43-6.

Aliramaji A, Kaseean A, Pasha YR, Shafi H, Kamali S, Safari M, Moudi E. Age distribution types of bladder cancers and their relationship with opium consumption and smoking. Caspian J Internal Med. 2015;6(2):82.

Payandeh M, Sadeghi M, Sadeghi E. Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran. Iranian J Cancer Prevent. 2015;8(6):1-4.

Ahmadi M, Ranjbaran H, Amiri MM, Nozari J, Mirzajani MR, Azadbakht M, Hosseinimehr SJ. Epidemiologic and socioeconomic status of bladder cancer in Mazandaran Province, northern Iran. Asian Pacific J Cancer Prevent. 2012;13(10):5053-6.

Farahmand M, Almasi-Hashiani A. Epidemiology of Bladder Cancers in Fars Province, Southern Iran (2003-2008). J Kerman Univ Med Sci. 2013;20(4):387-94.

Salehi A, Khezri AA, Malekmakan L, Aminsharifi A. Epidemiologic status of bladder cancer in Shiraz, southern Iran. Asian Pac J Cancer Prev. 2011;12(5):1323-7.

Taghavi A, Khorami M. The Causes of Delay to Diagnosis the Cancer of Bladder in Patients with Symptoms. J Isfahan Med School. 2011;29 (152):1155-60.

Fahmy N, Kassouf W, Jeyaganth S, Amin M, Mahmud S, Steinberg J, et al. An analysis of preoperative delays prior to radical cystectomy for bladder cancer in Quebec. Can Urol Assoc J. 2008;2(2):102-8.

Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND. Bladder cancer risk from occupational and environmental exposures. Urol Oncol. 2012;30(2):199–211.

Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC. Ultraviolet B Irradiance and Incidence Rates of Bladder Cancer in 174 Countries. Am J Preventive Med. 2010;38(3):296- 302.

Mohammadali F, Pourfathollah A. Association of ABO and Rh Blood Groups to Blood - Borne Infections a mong Blood Donors in Tehran - Iran. Iran J Public Health. 2014;43(7):981-9.

Sharp L, Donnelly D, Hegarty A, Carsin AE, Deady S, McCluskey N, Gavin A, Comber H. Risk of several cancers is higher in urban areas after adjusting for socioeconomic status. Results from a two-country population-based study of 18 common cancers. Journal of Urban Health. 2014;91(3):510-25.

Ramesht M, Pourfarzi F, Entezari M, Karamati H. An Epidemiologic Study of Spatial and Temporal Patterns of Gastric Cancer in Ardabil)Years 2006- 2012. J Health. 2015;6(3):345-54.

Downloads

Published

2018-02-24

How to Cite

Hoseinkhani, A., Amani, F., & Torabi, Y. (2018). Evaluation of clinical and laboratory characteristics of patients with bladder cancer in Ardabil province, 2016. International Journal Of Community Medicine And Public Health, 5(3), 885–889. https://doi.org/10.18203/2394-6040.ijcmph20180742

Issue

Section

Original Research Articles